N6-methyladenosine long non-coding RNAs reveal novel tool to implicate overall survival and immune microenvironment in renal clear cell carcinoma

[1]  Zhongfu Zhang,et al.  Targeted Methylation of the LncRNA NEAT1 Suppresses Malignancy of Renal Cell Carcinoma , 2021, Frontiers in Cell and Developmental Biology.

[2]  Xingkui Xue,et al.  LncRNA LINC00115 facilitates lung cancer progression through miR‐607/ITGB1 pathway , 2021, Environmental toxicology.

[3]  Yuqin Qiu,et al.  Integrated analysis on the N6‐methyladenosine‐related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma , 2021, Immunity, inflammation and disease.

[4]  Zhengtong Lv,et al.  Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer , 2021, Frontiers in Molecular Biosciences.

[5]  B. Li,et al.  Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma , 2021, BMC cancer.

[6]  Yao Lin,et al.  Identification of Epithelial–Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma , 2020, Frontiers in Oncology.

[7]  F. Tang,et al.  The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy , 2020, Journal of cellular physiology.

[8]  L. Lai,et al.  A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR , 2020, Cell Death & Disease.

[9]  A. Hakimi,et al.  Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma. , 2020, The Urologic clinics of North America.

[10]  K. Huang,et al.  N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients , 2020, Frontiers in Cell and Developmental Biology.

[11]  S. Ju,et al.  The potential role of RNA N6-methyladenosine in Cancer progression , 2020, Molecular Cancer.

[12]  Feng Wang,et al.  ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner , 2020, Annals of translational medicine.

[13]  M. Yi,et al.  LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma , 2020, Molecular oncology.

[14]  Chunlei Yuan,et al.  Long noncoding RNA LINC00115 promotes breast cancer metastasis by inhibiting miR‐7 , 2020, FEBS open bio.

[15]  Xuehao Wang,et al.  M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma , 2020, Journal of Hematology & Oncology.

[16]  F. Shimamoto,et al.  m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling , 2020, Molecular Cancer.

[17]  Xuedong Deng,et al.  lncRNA RPL34‐AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR‐3663‐3p/RGS4 in papillary thyroid cancer , 2020, Journal of cellular physiology.

[18]  Gang Yin,et al.  Functions of N6-methyladenosine and its role in cancer , 2019, Molecular Cancer.

[19]  Jia-feng Liang,et al.  RPL34-AS1 functions as tumor suppressive lncRNA in esophageal cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  E. Jonasch,et al.  MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma , 2019, Oncogene.

[21]  D. Lin,et al.  METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma , 2019, Molecular cancer.

[22]  A. Pircher,et al.  Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy , 2019, Front. Oncol..

[23]  Xiaoyu Chen,et al.  The role of m6A RNA methylation in human cancer , 2019, Molecular cancer.

[24]  X. Su,et al.  Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome1 , 2019, Neoplasia.

[25]  W. Zhai,et al.  A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma , 2019, Molecular Cancer.

[26]  Liuqing Yang,et al.  Molecular mechanisms of long noncoding RNAs‐mediated cancer metastasis , 2019, Genes, chromosomes & cancer.

[27]  R. Wunderink,et al.  Procalcitonin as a Biomarker in Rhinosinusitis: A Systematic Review , 2018, American journal of rhinology & allergy.

[28]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[29]  G. Freeman,et al.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.

[30]  Chuan He,et al.  Post-transcriptional gene regulation by mRNA modifications , 2016, Nature Reviews Molecular Cell Biology.

[31]  R. Gregory,et al.  The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. , 2016, Molecular cell.

[32]  A. Chinnaiyan,et al.  Long noncoding RNAs in cancer: from function to translation. , 2015, Trends in cancer.

[33]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[34]  Antonio Lopez-Beltran,et al.  Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. , 2015, European urology.

[35]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[36]  Howard Y. Chang,et al.  Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.

[37]  J. Larkin,et al.  Current and future systemic treatments for renal cell carcinoma. , 2013, Seminars in cancer biology.

[38]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[39]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[40]  M. van Engeland,et al.  VHL and HIF signalling in renal cell carcinogenesis , 2010, The Journal of pathology.